Serum midkine as a surrogate biomarker for metastatic prediction in differentiated thyroid cancer patients with positive thyroglobulin antibody-Reference-Cited by-同舟云学术

Serum midkine as a surrogate biomarker for metastatic prediction in differentiated thyroid cancer patients with positive thyroglobulin antibody

Published:2017-02-27 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Jia Qiang,Meng Zhaowei,Xu Ke,He Xianghui,Tan Jian,Zhang Guizhi,Li Xue,Liu Na,Hu Tianpeng,Zhou Pingping,Wang Sen,Upadhyaya Arun,Liu Xiaoxia,Wang Huiying,Zhang Chunmei

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep43516.pdf

Reference36 articles.

1. Cooper, D. S. et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19, 1167–1214, doi: 10.1089/thy.2009.0110 (2009).

2. Gerfo, P. L., Stillman, T., Colacchio, D. & Feind, C. Serum thyroglobulin and recurrent thyroid cancer. Lancet 1, 881–882 (1977).

3. Spencer, C., Petrovic, I., Fatemi, S. & LoPresti, J. Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications. The Journal of clinical endocrinology and metabolism 99, 4589–4599, doi: 10.1210/jc.2014-1203 (2014).

4. Weightman, D. R., Mallick, U. K., Fenwick, J. D. & Perros, P. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up. Cancer 98, 41–47, doi: 10.1002/cncr.11472 (2003).

5. Spencer, C. A. et al. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. The Journal of clinical endocrinology and metabolism 83, 1121–1127, doi: 10.1210/jcem.83.4.4683 (1998).

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical use of thyroglobulin: not only thyroid cancer;Endocrine;2024-01-06

2. Diagnostic performance of Midkine ratios in fine-needle aspirates for evaluation of Cytologically indeterminate thyroid nodules;Diagnostic Pathology;2021-10-25

3. Urinary iodine concentration and radioactive iodine therapeutic response in patients with differentiated thyroid cancer;Biomarkers in Medicine;2021-08

4. Prognostic value and dynamics of antithyroglobulin antibodies for differentiated thyroid carcinoma;Biomarkers in Medicine;2020-12

5. Blood prognostic predictors of treatment response for patients with papillary thyroid cancer;Bioscience Reports;2020-10